Back

A dual-phase study of a bioabsorbable venous vascular closure system: identifying predictors of failure and ensuring long-term safety in over 1,000 procedures

30 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Optimising atrial fibrillation ablation pathways: safety, access, and same-day discharge Clinical ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Takashi Kanda

Osaka Keisatsu Hospital, Osaka (Japan)

6 More presentations in this session

Presentation thumbnail
Pulsed-field ablation for atrial fibrillation in patients with chronic kidney disease: acute safety and efficacy
Doctor S. Iida (JP)
Abstract
Presentation thumbnail
The feasibility of same-day discharge for the epicardial component of convergent hybrid ablation
Doctor O. Ahmed (London, GB)
Abstract
Presentation thumbnail
Comparison of VASCADE MVP XL and Figure of 8 suture for vascular closure of the Faradrive sheath for pulsed field ablation
Doctor T. Tanko (Gainesville, US)
Abstract
Presentation thumbnail
Safety of hybrid epicardial–endocardial ablation in patients with persistent atrial fibrillation and heart failure with reduced left ventricular ejection fraction
Doctor O. Ahmed (London, GB)
Abstract
Presentation thumbnail
Same-day discharge after dual-energy ablation for atrial fibrillation
Doctor M. Lo (Little Rock, US)
Abstract

Access the full session

Session thumbnail
Optimising atrial fibrillation ablation pathways: safety, access, and same-day discharge

The Event

Event poster

ESC Congress 2026

30 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Resorbable venous closure system for vascular closure after single shot device by pulmonary vein isolation: The VASC-AF pilot study
12 April 2026
thumbnail
Congress Presentation
Vascular closure devices in TAVI: MANTA versus ProGlide in a propensity-matched population
28 August 2020
thumbnail
Congress Presentation
Bioresorbable vascular scaffolds - a single center experience
9 March 2024
thumbnail
Congress Presentation
Statseal venous closure device facilitates early ambulation following cryoablation of atrial fibrillation
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources